Normal growth and pubertal development during bromocriptine therapy in two patients with prolactinoma.
The cases of two boys, a 14 years 10 months old and an 18-year-old, with delayed puberty are presented. The first patient also had a short stature. Both patients had a pituitary adenoma, as shown by computed tomography, with high prolactin levels. After bromocriptine therapy was started, there was a spontaneous progression of normal puberty. The first patient used a synthetic growth hormone together with bromocriptine, however, even after the growth hormone was stopped progression in puberty and gain in height continued. The favorable response obtained in these patients implies that bromocriptine can be an effective therapy for adolescent patients with prolactinoma.
Kamel
N
N
Endocrinology and Metabolic Diseases Department, Ankara University, School of Medicine, Turkey.
Uysal
A R
AR
Cesur
V
V
Erdoğan
G
G
Başkal
N
N
D000293:Adolescent; D001971:Bromocriptine / Q000627:therapeutic use*; D018491:Dopamine Agonists / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D010911:Pituitary Neoplasms / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D011388:Prolactin / Q000097:blood; D015175:Prolactinoma / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D011627:Puberty / Q000187:drug effects*
D018491:Dopamine Agonists; D001971:Bromocriptine; D011388:Prolactin